Vitamin D and incidence of diabetes: A prospective cohort study

doi:10.1016/j.clnu.2011.12.001

Clinical Nutrition

Volume 31, Issue 4, August 2012, Pages 571-573

https://doi.org/10.1016/j.clnu.2011.12.001 Get rights and content

Summary

Background & aims

To investigate the relationship between levels of 25-hydroxyvitamin D and the incidence of type 2 diabetes in a Spanish population.

Methods

We undertook a population-based prospective study in a population from southern Spain. The first phase of the study (1996–1998) included 1226 individuals. Of this original cohort, 988 persons were reassessed in 2002–2004 and 961 in 2005–2007. Measurements were made of 25-hydroxyvitamin D and intact parathyroid hormone in 2002–2004 and an oral glucose tolerance test was done in three time points.

Results

The incidence of diabetes in subjects with 25-hydroxyvitamin D levels ≤18.5 ng/mL (percentile 25) was 12.4% vs 4.7% in subjects with levels >18.5 ng/mL. The likelihood of having diabetes during the four years of follow-up was significantly lower in the subjects with higher levels of 25-hydroxyvitamin D [OR = 0.17 (0.05–0.61)]. None of the subjects with levels higher than 30 ng/mL developed diabetes.

Conclusion

In this prospective study, we found a significant inverse association between serum 25-hydroxyvitamin D levels and the risk for type 2 diabetes in a population from the south of Spain.

Introduction

Vitamin D deficiency is an important public health problem because of its great impact on bone metabolism and the possible implication in cardiovascular outcomes, diabetes, cancer and mortality.¹ Even though Spain is a country with many hours of sunshine, most studies in Spain show a high prevalence of vitamin D deficiency.²

A complex relationship has been suggested between diabetes and vitamin D. Thus, increasing evidence suggests that vitamin D could have a causal role in the development of diabetes and the appearance of its complications.³ Cross-sectional studies have related vitamin D deficiency with the prevalence of diabetes,³ but there are only a few prospective cohort studies that had measured levels of 25-hydroxyvitamin D and incidence of type 2 diabetes with oral glucose tolerance test (OGTT) obtaining different results.4, 5, 6, 7 The aim of this study was to examine the relationship between serum levels of 25-hydroxyvitamin D and the incidence of type 2 diabetes in a representative sample of the Spanish population.

Section snippets

Material and methods

The study was carried out in a population-based cohort from Andalusia, southern Spain. The study population and the design of the survey have been described previously.⁸ The first phase of the study (1996–1998) included 1226 individuals, selected randomly from the municipal register of Pizarra, Malaga. Of this original cohort, 988 persons were reassessed in 2002–2004, and 961 in 2005–2007. At the second evaluation, we measured 25-hydroxyvitamin D and intact parathyroid hormone (iPTH),

Results

The mean age of the study participants was 50.3 ± 14.4 years, and 57% were women. The median 25-hydroxyvitamin D and iPTH concentrations were 22.4 ng/mL and 42.2 pg/mL, respectively. A multiple linear regression model showed that the concentration of 25-hydroxyvitamin D correlated significantly with iPTH: beta = −0.07 ± 0.01 (P < 0.0001). The 25 and 75 percentile of serum 25-hydroxyvitamin D were 18.5 ng/mL and 26.9 ng/mL respectively. After five years of follow-up there were 26 new cases of

Discussion

In this prospective study of a representative sample of the Spanish population, we found an inverse association between 25-hydroxyvitamin D plasma levels and the incidence of type 2 diabetes. Some of the proposed pathways by which vitamin D facilitates the development of diabetes concerns three mechanisms: 1 – vitamin D influence beta cell function (there are specific vitamin D receptors in pancreatic cells, 1-alfa-hydroxylase enzyme is expressed in pancreatic cells and there are vitamin D

Conflict of interest

The authors have no relevant conflict of interest to disclose.

Author contributions

IGM participated in the analysis of data, writing of the manuscript and provision of significant advice.

GR participated in the design, analysis of data, writing of the manuscript and provision of significant advice.

SM participated in the acquisition of data and provision of significant advice.

CGR participated in the analysis of data and provision of significant advice.

ERM participated in the analysis of data and provision of significant advice.

MCA participated in design and coordination and

Acknowledgments

Source of support: This study was undertaken with finance from the Fondo de Investigacion Sanitaria (PIO51307) and Junta de Andalucía (PIO258/2007, P06-CTS-01684) CIBER de Diabetes y Enfermedades metabólicas is an ISCII project.

References (10)

M.F. Holick
Vitamin D: extraskeletal health
Endocrinol Metab Clin North Am
(2010)
I. González-Molero et al.
Vitamin D deficiency in Spain: a population-based cohort study
Eur J Clin Nutr
(2011)
A.G. Pittas et al.
Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis
J Clin Endocrinol Metab
(2006)
N. Forouhi et al.
Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000
Diabetes
(2008)
C. Gagnon et al.
Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study)
Diabetes Care
(2011)

There are more references available in the full text version of this article.

Cited by (47)

The Effects of Vitamin D on Markers of Glucose and Obesity in Postmenopausal Women: A Meta-analysis of Randomized Controlled Trials
2023, Clinical Therapeutics
The effect of vitamin D effect on glucose markers and obesity in postmenopausal women remains controversial. The current literature contains little information on vitamin D dosage and duration for optimal efficacy in postmenopausal women. This meta-analysis was undertaken to assess the impact of vitamin D on glucose markers and obesity in postmenopausal women.
A number of databases were used dated up to January 5, 2023, with no language restrictions (PubMed/MEDLINE, Web of Science, EMBASE, and Scopus). Treatment response from baseline was estimated from the mean within-group analysis, and SDs were used to calculate the treatment response.
Nine eligible articles with 12 comparisons qualified for the final quantitative analysis. An overall decrease was noted in fasting blood glucose (weighted mean difference [WMD], –3.56 mg/dL; 95% CI, –5.49 to –1.64; P < 0.001), homeostatic model assessment for insulin resistance (WMD, –1.168 mm; 95% CI, –2.001 to –0.33; P = 0.006), insulin (WMD, –2.26 units; 95% CI, –4.35 to –0.18; P = 0.033), and glycosylated hemoglobin (WMD, –0.41%; 95% CI, –0.54 to –0.29; P < 0.001) after vitamin D administration in postmenopausal women. In subgroup analyses, a notable decrease in fasting blood glucose was detected when the intervention course was ˃6 months and dosage ≤1000 IU/d (WMD, –3.48 mg/dL). The present study showed that vitamin D was not associated with body mass index, body weight, or waist circumference in postmenopausal women.
Vitamin D is beneficial for glucose markers but not obesity in postmenopausal women. An individualized dosage regimen of vitamin D should be followed depending on the clinical outcome target of postmenopausal women.
The role of vitamin D in type 2 diabetes
2023, Feldman and Pike's Vitamin D: Volume Two: Disease and Therapeutics
Increasing evidence from animal and human studies point to an important role of vitamin D in modifying risk of type 2 diabetes. Vitamin D has both direct (through activation of the vitamin D receptor) and indirect (via regulation of calcium homeostasis) effects on various mechanisms related to the pathophysiology of type 2 diabetes, including pancreatic beta-cell dysfunction, impaired insulin action, and systemic inflammation. Longitudinal observational studies report highly consistent results showing inverse associations between measured blood 25(OH)D concentration and risk of developing type 2 diabetes. The results from mostly underpowered trials and post hoc analyses of large trials that used small doses of vitamin D do not support a role of vitamin D for treatment of established type 2 diabetes or prevention of diabetes among those with normal glucose tolerance; however, in people with prediabetes, vitamin D reduces risk of progression from prediabetes to diabetes and promotes regression to normal glucose regulation. For optimal risk reduction, blood 25(OH) levels higher than those recommended by the National Academy of Medicine are needed.
The role of systemic inflammation in the association between serum 25-hydroxyvitamin D and type 2 diabetes mellitus
2021, Clinical Nutrition
The association between serum 25-hydroxyvitamin D [25(OH)D] and type 2 diabetes mellitus (T2DM) remains inconclusive. Moreover, whether inflammatory biomarkers are involved in this association has not been explored. This study aims to investigate serum 25(OH)D in relation to T2DM in a Chinese population and provide clues for the inflammatory mechanism whereby serum 25(OH)D deficiency increases T2DM risk.
A cross-sectional study of 47,803 participants aged 18–96 years was performed in a health management center in 2017. Multivariate linear or logistic regression models and mediation analysis were used to examine the relationships between serum 25(OH)D, inflammatory biomarkers (white blood cell counts and mean platelet volume), and T2DM.
Of the 47,803 participants included, 5.2% were diabetic and 51.4% were serum 25(OH)D deficient. The study revealed a significant inverse association between serum 25(OH)D and T2DM risk after adjustment for potential confounders (P for trend = 0.002); the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) across serum 25(OH)D levels (sufficiency, insufficiency, and deficiency) were 1.00 (reference), 1.17 (1.03–1.33), and 1.25 (1.09–1.43), respectively. This study also showed a significant indirect effect of serum 25(OH)D on T2DM risk through total white blood cell count, neutrophil count, lymphocyte count, and monocyte count (P values < 0.05); the proportions mediated were 9.89%, 7.51%, 2.94%, and 2.82%, respectively.
Serum 25(OH)D deficiency was independently associated with an elevated risk of T2DM in a Chinese adult population and low-grade systemic inflammation might be one of its biological mechanisms.
Dietary program and physical activity impact on biochemical markers in patients with type 2 diabetes: A systematic review
2018, Atencion Primaria
Evaluate the effectiveness of the implementation of independently or combined dietary and physical activity programs on the blood glucose values and lipid profile in patients with type 2 diabetes, including participants aged 60 years and over.
Systematic review.
PubMed/Medline database, with language restrictions. Papers published between 2010 and 2016 were included.
A total of 30 randomised controlled trials were included that focused on physical activity and dietary interventions in patients with type 2 diabetes mellitus and include participants aged 60 years and over.
The selected articles have shown that the implementation of physical activity programs (aerobic, resistance, flexibility and combined exercises), and programs based on a higher intake of vegetables, grains, legumes, fruits, unsaturated fatty acids, as well as consumption of foods with low glycaemic index, calorie restriction, intake of probiotics, vitamin D supplementation and educational sessions about diabetes improves blood glucose levels, as well as the lipid profile, in patients with type 2 diabetes.
Physical activity and dietary programs are fundamental in the treatment and metabolic control of type 2 diabetes mellitus.
Evaluar la efectividad de la implementación de programas de actividad física y dietética independientemente o combinados en los valores de glucosa en sangre y perfil lipídico en pacientes con diabetes tipo 2, incluyendo participantes de 60 años y más.
Revisión sistemática.
PubMed/Medline, con restricciones de idioma. Se incluyeron artículos publicados entre 2010 y 2016.
Se incluyeron 30 estudios controlados aleatorios, centrados en la actividad física e intervenciones dietéticas en pacientes con diabetes tipo 2 que incluían sujetos de 60 años y más.
Los artículos seleccionados han demostrado que la implementación de programas de actividad física (ejercicios aeróbicos, resistencia, flexibilidad y ejercicios combinados) y programas basados en una mayor ingesta de vegetales, granos, legumbres, frutas, ácidos grasos insaturados, el consumo de alimentos con bajo índice glucémico, restricción calórica, ingesta de probióticos, suplementos de vitamina D y sesiones educativas sobre la diabetes mejoran los niveles glucémicos, así como el perfil lipídico en pacientes con diabetes tipo 2.
Los programas de actividad física y dietéticos son fundamentales en el tratamiento y control metabólico de la diabetes mellitus tipo 2.
Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
2018, Journal of Steroid Biochemistry and Molecular Biology
Citation Excerpt :
Similarly, those who live in higher altitudes also receive less exposure to UVB, and have a high prevalence of vitamin D deficiency, cardiovascular disease, and diabetes [18,72,73]. Many epidemiological and ecological studies have been published demonstrating close relationships between individual’s sun-exposure and/or the vitamin D status with T1D [74–76], T2D [15,37,77–86], insulin resistance [17,19,20,47,61,79–82,87–92], hypertension [33,86,93–101], and metabolic syndrome [90,91,102]. Diabetes is not only about the inability to handle glucose properly but is also an inflammatory disease [103,104].
The aim of this study is to determine the relationships of vitamin D with diabetes, insulin resistance obesity, and metabolic syndrome. Intra cellular vitamin D receptors and the 1-α hydroxylase enzyme are distributed ubiquitously in all tissues suggesting a multitude of functions of vitamin D. It plays an indirect but an important role in carbohydrate and lipid metabolism as reflected by its association with type 2 diabetes (T2D), metabolic syndrome, insulin secretion, insulin resistance, polycystic ovarian syndrome, and obesity. Peer-reviewed papers, related to the topic were extracted using key words, from PubMed, Medline, and other research databases. Correlations of vitamin D with diabetes, insulin resistance and metabolic syndrome were examined for this evidence-based review. In addition to the well-studied musculoskeletal effects, vitamin D decreases the insulin resistance, severity of T2D, prediabetes, metabolic syndrome, inflammation, and autoimmunity. Vitamin D exerts autocrine and paracrine effects such as direct intra-cellular effects via its receptors and the local production of 1,25(OH)₂D₃, especially in muscle and pancreatic β-cells. It also regulates calcium homeostasis and calcium flux through cell membranes, and activation of a cascade of key enzymes and cofactors associated with metabolic pathways. Cross-sectional, observational, and ecological studies reported inverse correlations between vitamin D status with hyperglycemia and glycemic control in patients with T2D, decrease the rate of conversion of prediabetes to diabetes, and obesity. However, no firm conclusions can be drawn from current studies, because (A) studies were underpowered; (B) few were designed for glycemic outcomes, (C) the minimum (or median) serum 25(OH) D levels achieved are not measured or reported; (D) most did not report the use of diabetes medications; (E) some trials used too little (F) others used too large, unphysiological and infrequent doses of vitamin D; and (G) relative paucity of rigorous clinical data on the effects of vitamin D sufficiency on non-calcium endpoints. Although a large number of observational studies support improving T2D, insulin resistance, obesity, and metabolic syndrome with vitamin D adequacy, there is a lack of conclusive evidence from randomized control clinical trials that, these disorders are prevented following optimization of serum levels of 25(OH)D. However, none of the currently conducted clinical studies would resolve these issues. Thus, specifically designed, new clinical studies are needed to be conducted in well-defined populations, following normalizing the serum vitamin D levels in vitamin D deficient prediabetes subjects, to test the hypothesis that hypovitaminosis D worsens these disorders and correction would alleviate it.
Non-musculoskeletal benefits of vitamin D
2018, Journal of Steroid Biochemistry and Molecular Biology
Citation Excerpt :
Although not studied yet, it is plausible that vitamin D supplementation early in the disease—the prediabetes stage, may prevent β-cell damage. Among the many possible mechanisms, reduction of inflammation [54,178,252], improved insulin sensitivity, and reduced insulin resistance have been proposed [50,52,53,253,254]. In addition, vitamin D has positive physiological effects on the regulation of plasma calcium levels, which indirectly regulate insulin synthesis and secretion, and also have actions on pancreatic β-cell function [50,255,256].
The aim of this study is to determine and critically evaluate the plausible relationships of vitamin D with extra-skeletal tissues in humans. Severe vitamin D deficiency results in rickets in children and osteomalacia in adults; these beneficial effects in the musculoskeletal system and certain physiological functions are well understood. Nevertheless, mounting reports support additional beneficial effects of vitamin D, outside the musculoskeletal system. This review explores the recent advances in knowledge about the non-skeletal effects of vitamin D. Peer-reviewed papers were extracted from research databases using key words, to assess correlations between vitamin D and extra-skeletal diseases and conditions. As per the guidelines of the Preferred Reporting Items for Systematic Reviews (PRISMA); general interpretations of results are included; taking into consideration the broader evidence and implications. This review summarizes current knowledge of the effects of vitamin D status on extra-skeletal tissues with special attention given to relationships between vitamin D status and various diseases commonly affecting adults; the effects of intervention with vitamin D and exposure to sunlight. Evidence suggests that vitamin D facilitates the regulation of blood pressure; and cardiac; endothelial; and smooth muscle cell functions; playing an important role in cardiovascular protection. In addition; 1,25(OH)₂D improves immunity; subdues inflammation; and reduces the incidence and severity of common cancers; autoimmune diseases and infectious diseases. Almost all adequately powered; epidemiological and biological studies that use; adequate doses of vitamin D supplementation in D-deficient populations have reported favorable outcomes. These studies have concluded that optimizing 25(OH)D status improves the functionality of bodily systems; reduces comorbidities; improves the quality of life; and increases survival. Although accumulating evidence supports biological associations of vitamin D sufficiency with improved physical and mental functions; no definitive evidence exists from well-designed; statistically powered; randomized controlled clinical trials. Nevertheless, most studies point to significant protective effects of vitamin D in humans when the minimum 25(OH)D serum level exceeds 30 ng/mL and is maintained throughout the year.

View all citing articles on Scopus

View full text

Short communicationVitamin D and incidence of diabetes: A prospective cohort study

Summary

Background & aims

Methods

Results

Conclusion

Introduction

Section snippets

Material and methods

Results

Discussion

Conflict of interest

Author contributions

Acknowledgments

Endocrinol Metab Clin North Am

Vitamin D deficiency in Spain: a population-based cohort study

Eur J Clin Nutr

Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis

J Clin Endocrinol Metab

Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000

Diabetes

Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study)

Diabetes Care

Short communication
Vitamin D and incidence of diabetes: A prospective cohort study